Imagine if you knew who was...
With these insights, now imagine how you could select and prioritize the right sites for activation to accelerate enrollment.
And imagine how risk-based monitoring coverage could be optimized to prevent errors and delays.
Trial sponsors and CROs deploy Ready to reveal these risks sooner and to better prepare their sites and decentralized teams to more effectively conduct their studies.
Learn how Ready has enabled clinical trial leaders to optimize SITE SELECTION and SITE INITIATION and to inform RISK-BASED MONITORING in their Phase 2 and Phase 3 studies.
Schedule time for your free consultation at SCOPE in Booth #220 and get your free copy of our upcoming Mitigating Trial Team Risk Report.
Re-imagine site selection and site initiation with Ready to inform faster operational decisions and to reduce the burden on your teams, sites, and decentralized staff. Train on-demand ahead of a site or home visit and watch your actual study documents come alive as sites and decentralized trial teams are directed to focus and engage around key study objectives. |
|
Identify how confident your teams and sites are in conducting the most critical aspects of your study – so you can identify risks earlier in the trial to make more informed oversight and faster operational decisions. |
|
Did you know 21 of the top 25
Pharmaceutical firms relied on
Ready to improve clinician
performance in 2021?